Study examines cost-effectiveness of medicare drug plans in schizophrenia and bipolar disorder
A new study published online today in the American Journal of Managed Care found that in Medicare Part D, generic drug coverage was cost-saving compared to no coverage in bipolar disorder and schizophrenia, while also improving ...
Feb 20, 2013
0
0